Effects of the Oxygen-Carrying Solution OxyVita C on the Cerebral Microcirculation and Systemic Blood Pressures in Healthy Rats
Source abstract
Abstract
The use of hemoglobin-based oxygen carriers (HBOC) as oxygen delivering therapies during hypoxic states has been hindered by vasoconstrictive side effects caused by depletion of nitric oxide (NO). OxyVita C is a promising oxygen-carrying solution that consists of a zero-linked hemoglobin polymer with a high molecular weight (~17 MDa). The large molecular weight is believed to prevent extravasation and limit NO scavenging and vasoconstriction. The aim of this study was to assess vasoactive effects of OxyVita C on systemic blood pressures and cerebral pial arteriole diameters. Anesthetized healthy rats received four intravenous (IV) infusions of an increasing dose of OxyVita C (2, 25, 50, 100 mg/kg) and hemodynamic parameters and pial arteriolar diameters were measured pre- and post-infusion. Normal saline was used as a volume-matched control. Systemic blood pressures increased (P ≤ 0.05) with increasing doses of OxyVita C, but not with saline. There was no vasoconstriction in small (<50 µm) and medium-sized (50–100 µm) pial arterioles in the OxyVita C group. In contrast, small and medium-sized pial arterioles vasoconstricted in the control group. Compared to saline, OxyVita C showed no cerebral vasoconstriction after any of the four doses evaluated in this rat model despite increases in blood pressure.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Hemoglobin structure and function · Heme Oxygenase-1 and Carbon Monoxide · Neuroscience of respiration and sleep
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
NeuroTrauma Department, Naval Medical Research Center (NMRC), Silver Spring, MD 20910, USA
Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20895, USA
Funding
Defense Health Program (DHP)
References (29)
Show source-provided references
1. Salvage of focal cerebral ischemic damage by transfusion of high O2-affinity recombinant hemoglobin polymers in mouse10.1152/japplphysiol.01374.2005 ↗
2. Decreased damage from transient focal cerebral ischemia by transfusion of zero-link hemoglobin polymers in mouse10.1161/STROKEAHA.108.526731 ↗
3. Transfusion of hemoglobin-based oxygen carriers in the carboxy state is beneficial during transient focal cerebral ischemia10.1152/japplphysiol.01079.2012 ↗
4. Cerebral circulation and metabolism after severe traumatic brain injury: The elusive role of ischemia10.3171/jns.1991.75.5.0685 ↗
5. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: A meta-analysis10.1001/jama.299.19.jrv80007 ↗
6. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin10.1038/nbt0798-672 ↗
7. No scavenging and the hypertensive effect of hemoglobin-based blood substitutes10.1016/j.freeradbiomed.2003.11.030 ↗
8. Intravascular retention and renal handling of purified natural and intramolecularly cross-linked hemoglobins
9. Oxygen therapeutics: Can we tame haemoglobin?10.1038/nrd1307 ↗
10. Enhanced molecular volume of conservatively pegylated hb: (SP-PEG5K)6-Hba is non-hypertensive10.1081/BIO-200066365 ↗
11. First-generation blood substitutes: What have we learned? Biochemical and physiological perspectives10.1517/14712598.7.5.665 ↗
12. Molecular design properties of OxyVita hemoglobin, a new generation therapeutic oxygen carrier: A review10.3390/jfb2040414 ↗
13. Production and characteristics of an infusible oxygen-carrying fluid based on hemoglobin intramolecularly cross-linked with sebacic acid10.1016/S0022-2143(96)90006-2 ↗
14. Physicochemical characteristics of oxyvita hemoglobin, a zero-linked polymer: Liquid and powder preparations10.3109/10731199.2010.501753 ↗
15. Vascular response to infusions of a nonextravasating hemoglobin polymer10.1152/japplphysiol.00191.2002 ↗
16. Pre-clinical studies using oxyvita hemoglobin, a zero-linked polymeric hemoglobin: A review10.1007/s10047-010-0528-6 ↗
17. Effects of top-loading a zero-link bovine hemoglobin, oxyvita, on systemic and microcirculatory variables10.7205/MILMED-D-12-00408 ↗
18. Effects of N-acetyl-L-cysteine and hyaluronic acid on HBOC-201-induced systemic and cerebral vasoconstriction in the rat10.2174/15701638113109990034 ↗
19. Cervos-Navarro, J., and Fritschka, E. (1981). Cerebral Microcirculation and Metabolism, Raven Press.
20. Cerebral microcirculation and oxygen tension in the human secondary cortex10.1007/s10439-013-0828-0 ↗
21. A brief communication: Age and species dependence of pial arteriolar responses to topical carbon monoxide in vivo10.3181/0705-BC-136 ↗
22. Detailed description of a cranial window technique for acute and chronic experiments10.1161/01.STR.6.3.308 ↗
23. Cerebral microcirculation in the mouse brain: Spontaneous and drug-induced changes in flow and vascular diameter10.1001/archneur.1963.00460100102012 ↗
24. Spectrophotometric studies: II. Preparations from washed blood cells; nitric oxide hemoglobin and sulfhemoglobin10.1016/S0021-9258(18)74965-X ↗
25. Micro determination of oxyhemoglobin, methemoglobin sulfhemoglobin in a singlesample of blood10.1016/S0021-9258(18)73873-8 ↗
26. CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats10.1038/bjp.2008.219 ↗
27. Dependence of acetylcholine and ADP dilation of pial arterioles on heme oxygenase after transfusion of cell-free polymeric hemoglobin10.1152/ajpheart.00500.2005 ↗
28. Cerebrovascular response to decreased hematocrit: Effect of cell-free hemoglobin, plasma viscosity, and CO210.1152/ajpheart.00077.2003 ↗
29. Pial arteriolar responses in mouse-brain revisited10.1161/01.STR.7.3.283 ↗